Correction to: British Journal of Cancer (2009) 101, 1909–1918. doi:10.1038/sj.bjc.6605405
Upon publication of this paper in the last issue, an error was spotted in the clinical data in Table 1 – Chip number IB54 was incorrectly listed twice, when in the second instance it should have been referred to as IB60. The correct data are now shown below.
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Additional information
The online version of the original article can be found at 10.1038/sj.bjc.6605405
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Cleton-Jansen, AM., Anninga, J., Briaire-de Bruijn, I. et al. Erratum: Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways. Br J Cancer 101, 2064 (2009). https://doi.org/10.1038/sj.bjc.6605482
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6605482
This article is cited by
-
Whole exome sequencing of a single osteosarcoma case—integrative analysis with whole transcriptome RNA-seq data
Human Genomics (2014)
-
Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy
BMC Medical Genomics (2014)
-
IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma
BMC Cancer (2013)
-
mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts
BMC Medical Genomics (2011)
-
Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy
BMC Cancer (2010)
